GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford BioDynamics PLC (LSE:OBD) » Definitions » EV-to-EBITDA

Oxford BioDynamics (LSE:OBD) EV-to-EBITDA : -2.53 (As of May. 21, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Oxford BioDynamics EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Oxford BioDynamics's enterprise value is £24.89 Mil. Oxford BioDynamics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was £-9.84 Mil. Therefore, Oxford BioDynamics's EV-to-EBITDA for today is -2.53.

The historical rank and industry rank for Oxford BioDynamics's EV-to-EBITDA or its related term are showing as below:

LSE:OBD' s EV-to-EBITDA Range Over the Past 10 Years
Min: -83.53   Med: -15.05   Max: -1.29
Current: -2.53

During the past 11 years, the highest EV-to-EBITDA of Oxford BioDynamics was -1.29. The lowest was -83.53. And the median was -15.05.

LSE:OBD's EV-to-EBITDA is ranked worse than
100% of 456 companies
in the Biotechnology industry
Industry Median: 10.52 vs LSE:OBD: -2.53

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-21), Oxford BioDynamics's stock price is £0.076. Oxford BioDynamics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.073. Therefore, Oxford BioDynamics's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Oxford BioDynamics EV-to-EBITDA Historical Data

The historical data trend for Oxford BioDynamics's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford BioDynamics EV-to-EBITDA Chart

Oxford BioDynamics Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -22.54 -18.71 -6.73 -2.71 -7.73

Oxford BioDynamics Semi-Annual Data
Sep13 Sep14 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.73 - -2.71 - -7.73

Competitive Comparison of Oxford BioDynamics's EV-to-EBITDA

For the Biotechnology subindustry, Oxford BioDynamics's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oxford BioDynamics's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oxford BioDynamics's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Oxford BioDynamics's EV-to-EBITDA falls into.



Oxford BioDynamics EV-to-EBITDA Calculation

Oxford BioDynamics's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=24.890/-9.841
=-2.53

Oxford BioDynamics's current Enterprise Value is £24.89 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford BioDynamics's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was £-9.84 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford BioDynamics  (LSE:OBD) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Oxford BioDynamics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.076/-0.073
=At Loss

Oxford BioDynamics's share price for today is £0.076.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Oxford BioDynamics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.073.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Oxford BioDynamics EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Oxford BioDynamics's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford BioDynamics (LSE:OBD) Business Description

Traded in Other Exchanges
Address
Oxford Business Park South, 3140 Rowan Place, John Smith Drive, Oxford, GBR, OX4 2WB
Oxford BioDynamics PLC is a biotechnology company. The company focuses on the discovery and development of biomarkers for use within the pharmaceutical and biotechnology industry. It provides a technology platform Episwitch which aims to accelerate the drug discovery and development process and improve the success rate of therapeutic product development. Geographically, the majority of revenue is from The United Kingdom.

Oxford BioDynamics (LSE:OBD) Headlines

No Headlines